N-Nitroso dabigatran Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner').N-Nitroso Dabigatran Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Dabigatran Impurity 1 CAS NO: 2892260-29-4 also known as N-Nitroso Dabigatran Etexilate or N-Nitroso dabigatran Impurity & it is chemically represented as ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Synchemia is the leading manufacturing and exporter of N-Nitroso Dabigatran Impurity 1 .We supply N-Nitroso Dabigatran Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143700 |
| CAS No | NA |
| Mol.F. | C11H13N5O2 |
| Mol.Wt. | 247.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143701 |
| CAS No | NA |
| Mol.F. | C18H22N6O6 |
| Mol.Wt. | 418.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143702 |
| CAS No | NA |
| Mol.F. | C18H18D4N6O6 |
| Mol.Wt. | 422.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143703 |
| CAS No | NA |
| Mol.F. | C24H27N9O5 |
| Mol.Wt. | 521.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143704 |
| CAS No | NA |
| Mol.F. | C22H25BrN8O2 |
| Mol.Wt. | 513.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143705 |
| CAS No | NA |
| Mol.F. | C22H26N8O2 |
| Mol.Wt. | 434.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143706 |
| CAS No | NA |
| Mol.F. | C28H32N8O6 |
| Mol.Wt. | 576.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143707 |
| CAS No | NA |
| Mol.F. | C27H33BrN8O4 |
| Mol.Wt. | 613.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143708 |
| CAS No | NA |
| Mol.F. | C6H12N2O2 |
| Mol.Wt. | 144.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143709 |
| CAS No | 89600-66-8 |
| Mol.F. | C6H10N2O |
| Mol.Wt. | 126.156 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143710 |
| CAS No | NA |
| Mol.F. | C6H10N2O2 |
| Mol.Wt. | 142.16g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143711 |
| CAS No | NA |
| Mol.F. | C13H20N6O |
| Mol.Wt. | 276.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143712 |
| CAS No | NA |
| Mol.F. | C13H20N6O |
| Mol.Wt. | 276.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143713 |
| CAS No | NA |
| Mol.F. | C15H12N2O2S |
| Mol.Wt. | 284.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143714 |
| CAS No | NA |
| Mol.F. | C52H57N15O4 |
| Mol.Wt. | 956.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143715 |
| CAS No | NA |
| Mol.F. | C15H15ClN6O5 |
| Mol.Wt. | 394.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |